Efficacy and Safety of Ypeginterferon Alfa-2b in Chronic Hepatitis C

Clinical trial NCT01140997 · COMPLETED

Trial details

NCT number: NCT01140997
Sponsor: Xiamen Amoytop Biotech Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Hepatitis C

Start date: 2010-07-01
Primary completion: 2011-01-01
Enrollment: 211

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.